Evaluation of cardiac autonomic function and low-grade inflammation in children with obesity living in the Northeast Brazilian region

Abstract Objective Evaluate autonomic function and low-grade inflammation and characterize the correlation between these variables in schoolchildren with obesity living in the Brazilian northeast region. Methods 84 children with obesity and 41 with normal weight were included in this cross-sectional study. Anthropometry, body composition, blood pressure (BP), inflammatory biomarkers, and heart rate variability (HRV) indexes were analyzed in children aged 7 to 11 years. Results children with obesity had increased systolic (p= 0.0017) and diastolic (p= 0.0131) BP and heart rate (p= 0.0022). The children with obesity displayed significantly lower SDNN, RMSSD, NN50, HF (ms), HF (nu), SD1, SD2, and higher LF (ms), LF (nu), LF/HF, SD1/SD2, DFA-α1, and DFA-α2, compared to normal weight. A lower and higher capacity for producing IL-10 (p= 0.039) and IL-2 (p= 0.009), respectively, were found in children with obesity compared to children with normal weight. Although IL-2, IL-4 and IL17A did not correlate with HRV parameters, IL-6 was positively correlated with SDNN, LF (ms) and SD2, TNF-α was positively correlated with LF/HF and SD1/SD2 ratio, and IFN-γ was positively correlated with SDNN, RMMSSD, NN50, LF (ms), HF (ms), SD1, and SD2. Conclusions The findings suggest that children with obesity have impaired autonomic function and systemic low-grade inflammation compared to children within the normal weight range, the inflammatory biomarkers were correlated with HRV parameters in schoolchildren living in the northeastern region of Brazil.

SARS-CoV-2 and Saliva: an update

Covid-19 is a respiratory disease caused by the SARS-CoV-2 virus. The high rate of contagion and the spread of the virus in the population make the early detection of the pathogen the means for the adequate targeting of infection control measures. WHO directs sample collection on upper respiratory specimens, including nasopharyngeal and oropharyngeal swab or wash in ambulatory patients, as well as lower respiratory specimens: sputum and/or endotracheal aspirate or bronchoalveolar lavage, in addition to citing blood and feces. Among the various sample collection methods, saliva has been investigated and reported as a potential source for diagnosis. Thus, we propose to evaluate the current scenario, based on recent publications on the perspective of detecting SARS-CoV-2 in saliva as a diagnostic method for Covid-19.

SARS-CoV-2 and Saliva as a Diagnostic Tool: A Real Possibility

Abstract Covid-19 is a respiratory disease caused by the SARS-CoV-2 virus. The high rate of contagion and the spread of the virus in the population make the early detection of the pathogen the means for the adequate targeting of infection control measures. WHO directs sample collection on upper respiratory specimens, including nasopharyngeal and oropharyngeal swab or wash in ambulatory patients, as well as lower respiratory specimens: sputum and/or endotracheal aspirate or bronchoalveolar lavage, in addition to citing blood and feces. Among the various sample collection methods, saliva has been investigated and reported as a potential source for diagnosis. Thus, we propose to evaluate the current scenario, based on recent publications on the perspective of detecting SARS-CoV-2 in saliva as a diagnostic method for Covid-19. The detection of SARS-CoV-2 through saliva seems to be very promising, although obstacles such as the technique and the location of the collection and the sample size of the research carried out so far may present a limitation for its use. The current scenario presents saliva as a reliable method for the detection of SARS-CoV-2, due to the ease of obtaining the samples, the possibility of self-collection, low cost because there is no need to use specific equipment, in addition to reducing the risk of transmission for health professionals.

Chikungunya virus infection with severe neurologic manifestations: report of four fatal cases.

Here, we present four patients with confirmed Chikungunya virus infection showing atypical neurologic manifestations and death. This case series includes patients ranging in age from five to 92 years, with or without comorbidities. This report is important, as very few cases in the literature reporting death due to atypical Chikungunya virus infection are available.

Chikungunya virus infection with severe neurologic manifestations: report of four fatal cases

Abstract Here, we present four patients with confirmed Chikungunya virus infection showing atypical neurologic manifestations and death. This case series includes patients ranging in age from five to 92 years, with or without comorbidities. This report is important, as very few cases in the literature reporting death due to atypical Chikungunya virus infection are available.

Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens.

INTRODUCTION: The relationships between monocytes and lymphocytes through MHC class II molecules and costimulatory, are of utmost importance for the production of an efficient immune response. In this work, we assessed the expression of surface molecules CD80 and CD86 on CD14+HLA-DR+ monocytes from patients with Chagas disease. METHODS:: The study population consisted of 31 patients with chronic clinical forms of Chagas disease. Patient blood samples were cultured in the presence of recombinant cytoplasmic repetitive antigen (CRA) and flagellar repetitive antigen (FRA). RESULTS:: We found considerable differences in the expression profile of surface molecules involved in antigen presentation. CONCLUSIONS:: CRA and FRA may contribute to host immune response evasion by Trypanozoma cruzi.

Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma

Non-Hodgkin's lymphoma (NHL) consists of a group of neoplasias involving mainly B cells and represents 90% of all lymphomas. The current available therapy is based on chemotherapy associated with the monoclonal antibody rituximab (Mab Thera(r)), which targets the CD20 protein, present in over 80% of NHL mature B cells. Recent clinical reports show a preference for combining the benefits of immunotherapy and adjuvant chemotherapy, thus generating safe and effective alternative treatments. The current review aimed at evaluating various aspects related to the use of rituximab for NHL, highlighting the possible inhibitory mechanisms of cell proliferation, the achieved clinical results, and the expected clinical and economic outcomes of treatments. The results from clinical tests indicate the need for a better understanding of the critical mechanisms of action of this antibody, which may maximize its therapeutic efficacy. This therapy not only represents a viable option to treat most types of NHLs, especially when associated with conventional chemotherapy, but also offers cost-utility and cost-effectiveness advantages.

O Linfoma não-Hodgkin (LNH) consiste em um grupo de neoplasias envolvendo, principalmente, as células B e representa 90% de todos os linfomas. A terapia atual disponível é baseada em quimioterapia associada ao anticorpo monoclonal rituximabe (Mab Thera(r)), que tem como alvo a proteína CD20, presente em mais de 80% das células B maduras do LNH. Recentes relatórios clínicos mostram preferência para combinar os benefícios da quimioterapia adjuvante e imunoterapia, gerando alternativas de tratamentos seguro e eficaz. O trabalho de revisão teve por objetivo avaliar vários aspectos relacionados à aplicação do rituximabe no LNH, destacando os possíveis mecanismos inibitórios da proliferação celular, os resultados clínicos obtidos e as implicações clínicas e econômicas esperadas para o tratamento. Os resultados de testes clínicos indicam a necessidade de uma melhor compreensão dos mecanismos críticos de ação deste anticorpo, que poderão maximizar a sua eficácia terapêutica. Essa terapia não representa apenas uma opção viável para o tratamento da maioria dos tipos de LNH, principalmente quando associado à quimioterapia convencional, mas, também, oferece vantagens em termos de custo-utilidade e custo-efetividade.

[Rotavirus prevalence in infants and children in the public healthcare system of the state of Pernambuco]. / Prevalência de rotavírus em crianças atendidas na rede pública de saúde do estado de Pernambuco.

INTRODUCTION: Rotaviruses are considered important etiological agents of acute gastroenteritis and a common cause of the hospitalization of children aged zero to four years-old. In Brazil, the incidence of rotavirus gastroenteritis in children is 12 to 42% and the distribution of infection is related to seasonality, which apparently occurs in different periods and intensity according to each region. The study investigated group A rotavirus in fecal samples of suspected children attended by the public health system of the State of Pernambuco. METHODS: Diagnosis was achieved by ELISA and the Latex agglutination test. RESULTS: Of the 171 samples studied, 33 (19.3%) presented positivity for Rotavirus A. Among positive samples, 72.7% belonged to male patients and 27.3% to female. Among the positive casuistic, 15.2% were vaccinated. When comparing the results obtained for the ELISA and Latex agglutination tests, 100% agreement between positivity by Latex agglutination and ELISA was verified. CONCLUSIONS: The high incidence of this infection reinforces the need to monitor this virus and define health policies concerning its diagnosis, prophylaxis, improvement in socioeconomic conditions and the refinement of the vaccine.

Prevalência de rotavírus em crianças atendidas na rede pública de saúde do estado de Pernambuco / Rotavirus prevalence in infants and children in the public healthcare system of the state of Pernambuco

INTRODUÇÃO: Os rotavírus são considerados, importantes agentes etiológicos de gastroenterite aguda e ainda causa comum de hospitalização de crianças na faixa etária de zero a quatro anos de idade. No Brasil, a incidência de rotavírus nas crianças com gastrenterite é de 12 a 42 por cento, e a distribuição da infecção esta relacionada à sazonalidade que aparentemente ocorre em diferentes períodos e intensidade de acordo com a região de ocorrência. O estudo pesquisou rotavírus do grupo A em amostras fecais de crianças com caso suspeito atendidas na rede pública de saúde do Estado de Pernambuco. MÉTODOS: O diagnóstico foi realizado através de ensaios imunoenzimático ELISA e teste imunoquímico de aglutinação em látex. RESULTADOS: Foram estudadas 171 amostras. Destas, 33 (19,3 por cento) apresentaram positividade. Das amostras positivas 24 (72,7 por cento) eram do sexo masculino e 09 (27,3 por cento) do sexo feminino. Dentro da amostragem positiva 15,2 por cento eram vacinadas. Quando comparamos os resultados obtidos entre o teste Elisa e aglutinação pelo Látex, houve 100 por cento de concordância entre a positividade pelo Látex e o ELISA. CONCLUSÕES: A alta incidência desta infecção reforça necessidade de monitoramento desse vírus, definindo políticas de saúde relacionadas ao diagnóstico, profilaxia, melhores condições sócio-econômicas e aprimoramento da vacina.

INTRODUCTION: Rotaviruses are considered important etiological agents of acute gastroenteritis and a common cause of the hospitalization of children aged zero to four years-old. In Brazil, the incidence of rotavirus gastroenteritis in children is 12 to 42 percent and the distribution of infection is related to seasonality, which apparently occurs in different periods and intensity according to each region. The study investigated group A rotavirus in fecal samples of suspected children attended by the public health system of the State of Pernambuco. METHODS: Diagnosis was achieved by ELISA and the Latex agglutination test. RESULTS: Of the 171 samples studied, 33 (19.3 percent) presented positivity for Rotavirus A. Among positive samples, 72.7 percent belonged to male patients and 27.3 percent to female. Among the positive casuistic, 15.2 percent were vaccinated. When comparing the results obtained for the ELISA and Latex agglutination tests, 100 percent agreement between positivity by Latex agglutination and ELISA was verified. CONCLUSIONS: The high incidence of this infection reinforces the need to monitor this virus and define health policies concerning its diagnosis, prophylaxis, improvement in socioeconomic conditions and the refinement of the vaccine.

Análise da expressão de carboidratos no estroma do carcinoma ductal invasivo da mama e sua correlação com dados clínicos e histopatológicos / Carbohydrates expression analysis in stroma of breast invasive ductal carcinoma and its correlation with clinical and histopathological datas

Objetivos: Analisar o perfil de carboidratos no estroma do carcinoma ductal invasivo, usando histoquímica com lectinas, e correlacionar os achados com dados clínicos e histopatológicos. Métodos: Estudo retrospectivo baseado na análise dos casos de 30 pacientes diagnosticados com carcinoma ductal invasivo durante o período de Maio a Outubro de 2008, As mostras tumorais foram submetidas a histoquímica com lectinas, na qual foram utilizadas as lectinas conjugadas à peroxidase: PNA-Per, 25 mg/mL, UEA-I-Per, 40 mg/mL e Con A-Per, 40 mg/mL específicas para D-galactose, L-fucose e glicose/manose, respectivamente. Posteriormente, os achados histoquímicos foram relacionados com os dados clínicos e histopatológicos (idade, invasão linfonodal, status para p53, tamanho tumoral e variante histológica) das pacientes. Resultados: Na histoquímica com lectinas, a Con A reconheceu a matriz extracelular em 53,33% dos casos, enquanto a PNA e a UEA-I reconheceram 30 e 40%. Já o endotélio de vasos sanguíneos foi mais reconhecido pela UEA-I (40% dos casos) que a Con A (10% dos casos). Biópsias de pacientes cuja matriz extracelular foi reconhecida pela Con A foram positivas também para p53 (p = 0,029), e todos os casos positivos para p53 (p = 0,041) tiveram os respectivos endotélios vasculares reconhecidos por essa lectina. O reconhecimento do estroma pela UEA-I em relação à variante histológica pouco diferenciada mostrou-se significativo (p = 0,034) em relação às demais variáveis analisadas. Conclusões: Os resultados indicaram o potencial das lectinas como sondas eficientes e os glicoconjugados de estroma como biomarcadores ou fonte de informações da biologia tumoral do carcinoma ductal invasivo.

Objectives: To analyze the carbohydrates profile in the stroma of invasive ductal carcinoma, using lectin histochemistry, and correlate the findings with clinical and histopathological data. Methods: Retrospective study based on analysis of 30 cases from patients previously diagnosed with invasive ductal carcinoma during the period from May to October 2008. Tumour samples were subjected to the lectin histochemistry technique, in which the peroxidase-conjugated lectins were used: PNA-Per, 25 mg/mL, UEA-I-Per, 40 mg/mL e Con A-Per, 40 mg/mL specifics for D-galactose, L-fucose and glucose/mannose respectively. Subsequently the histochemical findings were correlated with clinical and histopathological data (age, lymph node invasion, status to p53, tumor size and histological variant) of the patients. Results: In lectin histochemistry, the Con A stained the extracellular matriz of 53.33% of cases, while the PNA and UEA-I recognized 30 and 40% of the ECM, respectively. The blood vessels endothelium was most recognized by the lectin UEA-I (40%) than Con A (10%). Biopsies from patients with ECM stained by Con A were also positive for p53 (p = 0.029), and all positive cases to p53 (p = 0.041) had the respective endothelium recognized by the same lectin. The ECM staining by the UEA-I in relation to poorly differentiated histological variant showed a significant difference (p = 0.034) between the variants analyzed. Conclusions: The results indicated the potential of lectins as efficient probres and stromal glycoconjugates as biomarker or source of information in the diagnosis of invasive ductal carcinoma.

Resposta atenuada ao PPD no diagnóstico de infecção tuberculosa latente em pacientes com artrite reumatoide / Attenuated response to PPD in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis

INTRODUÇÃO: A utilização dos anti-TNF's na prática reumatológica tornou obrigatória a identificação de casos de infecção tuberculosa latente (ITBL) antes do início do tratamento, utilizando o PPD, RX de tórax e história de contato com tuberculose. Os pacientes com artrite reumatoide (AR) apresentam uma anormalidade da função celular imune, caracterizada por diminuição da responsividade de células mononucleares periféricas (linfócitos T Reg), o que acarreta prejuízo para a hipersensibilidade cutânea tardia, o que é fundamental para o reconhecimento de antígenos, como é o caso do PPD. OBJETIVOS: Avaliar a resposta ao PPD em pacientes com AR, comparado com pessoas saudáveis em uma área endêmica de tuberculose, como é o estado de Pernambuco. METODOLOGIA: Foram estudados 96 pacientes, 48 com AR e 48 indivíduos saudáveis, sendo a maioria do sexo feminino; foi realizada a inoculação de 0,1 mL do PPD RT-23, por via intradérmica e leitura da induração 72 horas após. RESULTADOS: No grupo AR o tempo médio de diagnóstico foi de 10,2 anos, a dose média de metotrexate foi de 15,5 mg/semana, dose média de prednisona foi de 12,7 mg/dia e a atividade média da doença medida pelo CDAI foi 30,4. Houve maior positividade do PPD no grupo de comparação (33,3 por cento) quando comparado com o grupo AR (14,6 por cento), com diferença estatisticamente significante (p = 0,034). CONCLUSÕES: Os autores alertam para o fraco desempenho do PPD para diagnóstico de ITBL em pacientes com AR e da necessidade de se fazer uma triagem ainda mais cuidadosa antes do início do tratamento com anti-TNF.

INTRODUCTION: With the introduction of Tumor Necrosis Factor Inhibitors (anti-TNFs) into rheumatological practice, it has become obligatory to identify cases of latent tuberculosis infection (LTBI) prior to the start of treatment, using PPD, chest radiography and clinical history of tuberculosis contact. Patients with Rheumatoid Arthritis (RA) have an abnormality of the cellular immune function, characterized by decreasing responsiveness of peripheral mononuclear cells (T Reg lymphocytes), leading to a loss in delayed hypersensitivity, which is fundamental for the recognition of antigens, such as PPD. OBJECTIVES: The purpose of our study was to evaluate the response to PPD in patients with RA, compared with healthy people, in an area where tuberculosis is endemic, as is the state of Pernambuco. METHODOLOGY: We studied 96 patients, 48 with RA and 48 healthy subjects, most of them females. All patients were given an interdermic injection of 0.1 mL PPD RT-23. The reading of the PPD result was carried out 72 hours after application, by way of palpation of maximum transverse diameter of induration, and the result was expressed in millimeters. RESULTS: In the RA group, the average time of diagnosis was 10.2 years, the average dosage of methotrexate was 15.5 mg / week, the average dosage of prednisone 12.7 mg / day and the average activity of the disease, measured using CDAI, was 30.4. In the healthy subjects group there was a greater number of positive PPD results (33.3 percent) when compared with the results for the RA group (14.6 percent), with a statistically significant difference (p = 0.034). CONCLUSION: The performance of PPB in LTBI diagnosis is poor in patients with RA. These results suggest that more careful screening needs to be undertaken before treatment with an anti-TNF drug.

Cytokine profile associated with chronic and acute human schistosomiasis mansoni.

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma (IFN-gamma) was evaluated in 43 schistosomiasis patients with different clinical forms. Whole-blood cultures cytokine production in response to soluble egg antigen (SEA), soluble worm adult preparation (SWAP), mitogens, neutralizing antibodies or recombinant IL-13 were measured by ELISA. After SWAP stimulation, chronic patients, particularly hepatointestinals, produced higher levels of IL-4 in comparison with acute patients, suggesting the presence of a type 2 cytokine profile in these patients. Following SEA and SWAP stimulation, hepatosplenic (HS) patients showed increased levels of IFN-gamma when compared with acute patients, indicating that HS disease in humans is associated with a type 1 cytokine response. The mechanisms of immune regulation are apparently different between the clinical stages of the disease, some of which are antigen-specific.

Cytokine profile associated with chronic and acute human schistosomiasis mansoni

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma (IFN-³) was evaluated in 43 schistosomiasis patients with different clinical forms. Whole-blood cultures cytokine production in response to soluble egg antigen (SEA), soluble worm adult preparation (SWAP), mitogens, neutralizing antibodies or recombinant IL-13 were measured by ELISA. After SWAP stimulation, chronic patients, particularly hepatointestinals, produced higher levels of IL-4 in comparison with acute patients, suggesting the presence of a type 2 cytokine profile in these patients. Following SEA and SWAP stimulation, hepatosplenic (HS) patients showed increased levels of IFN-³ when compared with acute patients, indicating that HS disease in humans is associated with a type 1 cytokine response. The mechanisms of immune regulation are apparently different between the clinical stages of the disease, some of which are antigen-specific.

The effect of Zymomonas mobilis culture on experimental Schistosoma mansoni infection

Camundongos C57Bl/10 do sexo masculino, infectados com Schistosoma mansoni foram distribuídos nos grupos misto, profilático e curativo. Cultura de Zymomonas mobilis foi administrada oralmente aos camundongos. Uma proteção de 61% foi observada no grupo curativo (p<0,05). Os estudos histopatológicos dos fígados e intestinos mostraram resultados similares.

Studies on the production and regulation of interleukin, IL-13, IL-4 and interferon-gamma in human Schistosomiasis mansoni

The production and regulation of interleukin (IL) IL-13, IL-4 and interferon-gamma was evaluated in different clinical forms of human schistosomiasis. The mechanisms of immune regulation are apparently different in the various clinical stages of the disease, some of them being antigen specific